Multithread effectively and personalize outreach to convert deals faster
Elevate social presence and drive business growth from social media
Identify and prioritize high-intent leads, and improve sales effectiveness
Find and connect with ICP attendees, and improve event outcomes
Entera Bio Ltd. is a clinical-stage biopharmaceutical company focused on the development and commercialization of orally delivered large molecule therapeutics for unmet medical needs. The company's proprietary oral drug delivery platform is designed to enable the absorption of large molecules and biologics in an oral form that are otherwise typically delivered via injection. Entera Bio's lead product candidates include EB613 for the treatment of osteoporosis and EB612 for the treatment of hypoparathyroidism. The company aims to provide more convenient and patient-friendly alternatives to existing injectable treatments.
Serves as the global headquarters, housing corporate leadership, research and development (R&D) laboratories, and administrative operations.
Modern laboratory and office facilities supporting advanced biopharmaceutical research within the Minrav Building.
A collaborative and innovative environment focused on scientific discovery and therapeutic development, characterized by a dedicated team aiming to advance oral drug delivery technologies.
Strategically located in Jerusalem, a growing hub for life sciences in Israel, providing access to skilled talent, research institutions, and a supportive biotech ecosystem.
While headquartered in Israel, Entera Bio's operations have a global reach primarily through its clinical trials, which may be conducted in various international locations to ensure diverse patient populations and meet regulatory requirements. The company also engages with the global investment community and seeks potential future commercialization partnerships on an international scale. Its therapeutic candidates are being developed to address medical needs for patients worldwide.
Kiryat Hadassah, Minrav Building – 5th Floor, P.O. Box 12158
Jerusalem
Jerusalem District
Israel
No additional office locations available.
Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.
As of April 2025, Entera Bio Ltd.' leadership includes:
Entera Bio Ltd. has been backed by several prominent investors over the years, including:
Over the past 12 months, Entera Bio has undertaken significant leadership restructuring, including the appointment of a new CEO, CBO, and CTO, and the departure of its former CEO. These changes aim to steer the company through its next phase of clinical development and strategic growth.
Discover the tools Entera Bio Ltd. uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.
Entera Bio likely utilizes common corporate email formats. While specific formats are not publicly confirmed by the company, patterns often involve combinations of the employee's first name, last name, or initials followed by '@enterabio.com'.
[first].[last]@enterabio.com
Format
miranda.toledano@enterabio.com
Example
85%
Success rate
GlobeNewswire • March 28, 2024
Entera Bio announced its financial results for the full year ended December 31, 2023, and provided updates on its clinical programs, including progress on EB613 for osteoporosis and EB612 for hypoparathyroidism, highlighting plans for a Phase 2b study for EB613....more
GlobeNewswire • February 20, 2024
Entera Bio announced the enrollment of the first patient in its Phase 1 clinical trial for EB612, an oral formulation of human parathyroid hormone (1-34), or PTH, for the treatment of hypoparathyroidism....more
GlobeNewswire • October 2, 2023
Entera Bio announced the appointment of Arthur M. Suckow, Ph.D., as its Chief Technology Officer, effective October 1, 2023. Dr. Suckow brings extensive experience in biopharmaceutical development and manufacturing to the role....more
See where a company’s workforce is located, by country or region.
View past and recent funding rounds with amounts and investors.
Understand company revenue estimates and financial scale.
Track active roles and hiring trends to spot growth signals.
Discover what a company offers—products, platforms, and solutions.
Get the company’s official SIC and NAICS classifications.
Analyze visitor volume, engagement, and top traffic sources.
Explore LinkedIn, Twitter, and other active social profiles.
Identify top competitors based on similar business traits.
Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.
Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.
Thousands of companies, including Entera Bio Ltd., are just a search away.